| 2017 |
Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records
10.1038/bjc.2017.127
Authors: L. Mounce, S. Price, J. Valderas, W. Hamilton |
| 2021 |
Comorbid diseases and conditions in people with HIV in the UK
10.1080/03007995.2021.2003671
Authors: B. Jones, A. Freedman, M. Thomas, C. Villalba-Mendez, L. Sathia, D. Flanagan, S. Francis, C. Currie |
| 2013 |
Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding
10.1053/j.gastro.2013.02.040
Authors: C. Crooks, J. West, T. Card |
| 2012 |
Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis
10.1155/2012/291704
Authors: H. Li, E. Hodgson, L. Watson, A. Shukla, J. Nelson |
| 2016 |
Comorbidities in patients with gout prior to and following diagnosis: case-control study
10.1136/annrheumdis-2014-206410
Authors: C. Kuo, M. Grainge, C. Mallen, W. Zhang, M. Doherty |
| 2020 |
Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: A case control and cohort study
10.1016/j.semarthrit.2020.05.003
Authors: R. Partington, S. Muller, C. Mallen, Abdul Sultan, T. Helliwell |
| 2012 |
Comorbidities in Perthes\textquoteright disease: a case control study using the General Practice Research database
10.1302/0301-620x.94b12.29974
Authors: D. Perry, C. Bruce, D. Pope, P. Dangerfield, M. Platt, A. Hall |
| 2009 |
Comorbidities of idiopathic thrombocytopenic purpura: a population-based study
10.1155/2009/963506
Authors: M. Feudjo-Tepie, G. Le Roux, K. Beach, D. Bennett, N. Robinson |
| 2015 |
Comorbidities, bone-sparing agent prescription history and their determinants among postmenopausal women in UK primary care settings: a retrospective database study
10.1007/s11657-015-0233-4
Authors: M. Feudjo-Tepie, S. Ferguson, A. Roddam, A. Taylor, J. Bayly, C. Critchlow |
| 2016 |
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis
10.1007/s12325-016-0346-1
Authors: F. Nyberg, L. Horne, R. Morlock, J. Nuevo, C. Storgard, L. Aiyer, D. Hines, X. Ansolabehere, P. Chevalier |
| 2019 |
Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality
10.1111/ene.14040
Authors: I. Chou, C. Kuo, R. Tanasescu, C. Tench, C. Tiley, C. Constantinescu, W. Whitehouse |
| 2016 |
Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population
10.1002/pds.4074
Authors: R. de Jong, A. Gallagher, E. Herrett, A. Masclee, M. Janssen-Heijnen, F. de Vries |
| 2022 |
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting
10.2147/copd.s370540
Authors: D. Halpin, K. Rothnie, V. Banks, A. Czira, C. Compton, R. Wood, T. Tritton, O. Massey, R. Wild, N. Snowise, K. Nikitin, R. Sharma, A. Ismaila, C. Vogelmeier |
| 2018 |
Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
10.2147/clep.s164112
Authors: S. Khalid, S. Calderon-Larranaga, S. Hawley, M. Ali, A. Judge, N. Arden, T. Van Staa, C. Cooper, M. Javaid, D. Prieto-Alhambra |
| 2014 |
Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers
10.1016/j.tmaid.2014.08.005
Authors: S. Toovey, K. Nieforth, P. Smith, P. Schlagenhauf, M. Adamcova, I. Tatt, D. Tomianovic, G. Schnetzler |
| 2004 |
Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol
10.1111/j.1365-2125.2004.02098.x
Authors: S. Hennessy, W. Bilker, J. Knauss, S. Kimmel, D. Margolis, M. Morrison, R. Reynolds, D. Glasser, B. Strom |
| 2019 |
Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study
10.1111/dom.13893
Authors: A. Douros, S. Dell'Aniello, O. H. Y. Yu, S. Suissa |
| 2021 |
Comparative differences in musculoskeletal pain consultation and analgesic prescription for people with dementia: a UK-wide matched cohort study
10.1097/j.pain.0000000000002257
Authors: L. Bullock, J. Bedson, Y. Chen, C. Chew-Graham, P. Campbell |
| 2018 |
Comparative effect of statins on the risk of incident Alzheimer disease
10.1212/wnl.0000000000004818
Authors: L. Sinyavskaya, S. Gauthier, C. Renoux, S. Dell'Aniello, S. Suissa, P. Brassard |
| 2020 |
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study
10.1002/pds.5181
Authors: Rustem Gulluoglu, P. Souverein, H. van den Ham, A. de Boer, J. Komen |
| 2019 |
Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice
10.1016/j.chest.2019.03.005
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2020 |
Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes
10.1111/dom.14169
Authors: F. Zaccardi, E. Jacquot, V. Cortese, F. Tyrer, S. Seidu, M. Davies, K. Khunti |
| 2016 |
Comparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users
10.1097/md.0000000000003995
Authors: J. Gamble, J. Thomas, L. Twells, W. Midodzi, S. Majumdar |
| 2021 |
Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study
10.1080/15412555.2021.1877649
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2018 |
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study
10.1016/s2213-2600(18)30368-0
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2018 |
Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
10.1136/bmjopen-2017-019638
Authors: S . Y. Loo, J. Coulombe, S. Dell'Aniello, J. Brophy, S. Suissa, C. Renoux |
| 2017 |
Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study
10.1016/j.jaip.2016.12.028
Authors: C. Murray, M. Thomas, K. Richardson, D. Price, S. Turner |
| 2023 |
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
10.2147/copd.s408688
Authors: G. Requena, A. Czira, V. Banks, R. Wood, T. Tritton, C. Castillo, J. Yeap, R. Wild, C. Compton, K. Rothnie, F. Herth, J. Quint, A. Ismaila |
| 2023 |
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
10.2147/copd.s405498
Authors: A. Czira, G. Requena, V. Banks, R. Wood, T. Tritton, C. Castillo, J. Yeap, R. Wild, C. Compton, K. Rothnie, F. Herth, J. Quint, A. Ismaila |
| 2019 |
Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD
10.1016/j.chest.2019.11.007
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2020 |
Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care
10.1111/dom.13970
Authors: S. Wilkinson, E. Williamson, A. Pokrajac, D. Fogarty, H. Stirnadel-Farrant, L. Smeeth, I. Douglas, L. Tomlinson |
| 2016 |
Comparative estimated effectiveness of antibiotic classes as initial and secondary treatments of respiratory tract infections: longitudinal analysis of routine data from UK primary care 1991-2012
10.1185/03007995.2016.1157459
Authors: E. Berni, C. Butler, S. Jenkins-Jones, H. de Voogd, M. Ouwens, C. Morgan, C. Currie |
| 2015 |
Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database
10.1016/j.jacc.2015.08.033
Authors: H. van den Ham, O. Klungel, D. Singer, H. Leufkens, T. van Staa |
| 2022 |
Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
10.1007/s00198-021-06262-1
Authors: S. Khalid, S. Calderon-Larranaga, A. Sami, S. Hawley, A. Judge, N. Arden, T. van Staa, C. Cooper, B. Abrahamsen, M. Javaid, D. Prieto-Alhambra |
| 2016 |
Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records
10.1111/dom.12692
Authors: S. Zghebi, D. Steinke, M. Rutter, R. Emsley, D. Ashcroft |
| 2022 |
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
10.1136/bmj-2022-071594
Authors: X. Li, E. Burn, T. Duarte-Salles, C. Yin, C. Reich, A. Delmestri, K. Verhamme, P. Rijnbeek, M. Suchard, K. Li, M. Mosseveld, L. John, M. Mayer, J. Ramirez-Anguita, C. Cohet, V. Strauss, D. Prieto-Alhambra |
| 2018 |
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes
10.1038/s41598-018-33483-y
Authors: J. Gamble, J. Donnan, E. Chibrikov, L. Twells, W. Midodzi, S. Majumdar |
| 2019 |
Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care
10.1007/s40265-019-01224-8
Authors: D. Price, V. Carter, J. Martin, E. Gardener, D. Skinner, S. Yang, M. Hoffman, J. Willis, A. Cooper |
| 2022 |
Comparing antibiotic prescribing between clinicians in UK primary care: an analysis in a cohort study of eight different measures of antibiotic prescribing
10.1136/bmjqs-2020-012108
Authors: T. Van Staa, Y. Li, N. Gold, T. Chadborn, W. Welfare, V. Palin, D. Ashcroft, J. Bircher |
| 2022 |
Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England
10.1016/s2666-7568(22)00186-6
Authors: Y . Y. Tan, V. Papez, W. Chang, S. Mueller, S. Denaxas, A. Lai |
| 2020 |
Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study
10.1186/s12883-019-1587-9
Authors: S. Borghs, L. Byram, J. Chan, P. Dedeken, J. Logan, V. Kiri, M. Noack-Rink, P. Patsalos, S. Thieffry |
| 2021 |
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety
10.1016/j.rmed.2021.106645
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2013 |
Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study
10.1093/fampra/cms060
Authors: S. Brilleman, C. Salisbury |
| 2020 |
Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis
10.1093/aje/kwaa242
Authors: T. Tran, S. Suissa |
| 2024 |
Comparing the clinical practice and prescribing safety of locum and permanent doctors: observational study of primary care consultations in England
10.1186/s12916-024-03332-z
Authors: C. Grigoroglou, K. Walshe, E. Kontopantelis, J. Ferguson, G. Stringer, D. Ashcroft, T. Allen |
| 2011 |
Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations
10.2165/11584970-000000000-00000
Authors: R. Charlton, J. Weil, M. Cunnington, S. Ray, C. de Vries |
| 2022 |
Comparing the number and length of primary care consultations in people with and without intellectual disabilities and health needs: observational cohort study using electronic health records
10.1093/fampra/cmac135
Authors: F. Tyrer, R. Morriss, R. Kiani, S. Gangadharan, H. Kundaje, M. Rutherford |
| 2020 |
Comparison of antibiotic prescribing records in two UK primary care electronic health record systems: cohort study using CPRD GOLD and CPRD Aurum databases
10.1136/bmjopen-2020-038767
Authors: M. Gulliford, X. Sun, T. Anjuman, E. Yelland, T. Murray-Thomas |
| 2020 |
Comparison of antihypertensive drug classes for dementia prevention
10.1097/ede.0000000000001245
Authors: V. Walker, N. Davies, R. Martin, P. Kehoe |
| 2003 |
Comparison of area-based inequality measures and disease morbidity in England, 1994\textendash1998.
Authors: J Hoare |
